NCT06938204View on ClinicalTrials.gov

Single Ascending Dose, Multiple Ascending Dose, Food Effect Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 9, 2024

Study Completion Date

September 13, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

INV-101

SAD MAD

DRUG

INV-101 Placebo

SAD MAD

Trial Locations (1)

02451

Pharmaron, Baltimore

Sponsors
All Listed Sponsors
lead

Innovo Therapeutics, Inc.

INDUSTRY

NCT06938204 - Single Ascending Dose, Multiple Ascending Dose, Food Effect Study | Biotech Hunter | Biotech Hunter